Skip to content
Contact us
Brand Builder Splash
BRAND BUILDER
 

Turning Pharma Brand Launch from Chaos to Clarity

Brand Builder provides biopharma commercial teams with the market insights necessary to support every key marketing decision throughout the clinical development process. Built on the proprietary PHYCURE™ framework — a seven-dimension strategic model covering patient targeting, competitive landscape, unmet needs, and emotional benefits.
 
Get a Launch Readiness Assessment

Most Pharma Launches Lack Full Strategic Clarity

Fragmented Research, Incomplete Picture
Most market research vendors focus on one slice of the launch journey — a standalone landscape study, a single positioning workshop, or a messaging test. Without a unifying framework, findings don't connect, and teams enter launch without a coherent strategic foundation.
One-Size-Fits-All Methodology
Traditional research vendors prioritize quantity over quality, applying the same approach regardless of whether your brand is first-in-class, a next-generation therapy, or a new entrant in an established market. The result is generic insight that doesn't reflect your brand's unique competitive context.
Research That Can't Keep Up
Typical market research services offer little flexibility or adaptation to changing circumstances. As trial data evolves and the competitive landscape shifts, rigid research programs leave teams reacting rather than anticipating.
BB

Brand Builder

One Framework. A Complete Launch Strategy.
Brand Builder is the only pharma brand launch research program built around PHYCURE™ — a proprietary seven-dimension strategic framework that maps every major launch decision to a dedicated research workstream. Unlike traditional market research services, Brand Builder offers facilitated discovery and decision-making that is complete, customized, and consultative.
 
P
Patient Target

P

What characteristics identify patients who are good candidates for your brand?

 
H
HCP Target

H

What characteristics identify physicians most likely to prescribe in higher volumes?

 
Y
Yes Journey

Y

What decision milestones and influencers shape behavioral Rx and compliance decisions?

 
C
Competitive Landscape

C

What other treatments do target HCPs consider for target patients when making Rx decisions?

 
U
Unmet Needs

U

What functional and emotional needs are not sufficiently met by competitors?

 
R
Rational Benefits

R

What are the unique and relevant functional outcomes for target patients and HCPs?

 
E
Emotional Benefits

E

What are the unique and relevant emotional benefits for target patients and HCPs?

Three Core Value Pillars

Complete
Complete
No Strategic Blind Spots

Brand Builder's integrated program ensures every PHYCURE™ dimension is addressed before you go to market, leaving no blind spot for competitors to exploit.

 

Customized
Customized
Built for Your Brand's Reality
Brand Builder's diagnostic evaluation ensures the methodology, sequencing, and scope reflect your brand's actual competitive reality — not a template inherited from another launch.
Consultative
Consultative
From Research to Readiness
Brand Builder's consultative model closes the gap between insight and action, working directly with your commercial team until findings translate into a launch strategy your organization can execute with confidence.
Download Capabilities

From Late Phase II to Launch — Four Key Marketing Decisions

Brand Builder supports four sequential marketing decisions across the clinical development timeline:

BB 1
Late Phase II → Market Assessment
 
Understand the competitive landscape, treatment dynamics, and patient and physician targeting before Phase III begins.
BB 2
Phase III → Establish Strategic Positioning

 
Define where your brand fits in the market and what differentiates it from existing and emerging therapies.

BB 3
Phase III to Launch → Identify Core Messaging
 
Develop and validate the rational and emotional messages that will resonate with your target HCP and patient audiences.
BB 4
Launch → Develop Creative Collateral
 
Translate strategic insights into creative direction and promotional materials ready for market entry.

Our Diagnostic Approach Builds a Research Program as Unique as Your Brand

We know that no two brands are alike. Like people, each brand has its own unique personality. Our diagnostic approach analyzes your brand across five key dimensions and customizes the research program accordingly:

Dimension Options
Competitive Context First in class / Next generation / New entry in established class
Audience Specialist-centric / Primary care-centric / Patient-centric / Payer-centric
Unmet Needs Emotion-driven / Function-driven / Outcomes-driven
Messaging Efficacy-focus / Safety-focus / Convenience-focus / Value-focus
Revenue Potential Higher / Moderate / Lower

 

Brand Builder vs. Traditional Launch Research Vendors

Group 40648 (1)

Brand Builder
Group 40649 (1)
Traditional Market Research
Coverage Integrated program from mid-Phase III through post-launch Focuses on one part of a brand's lifecycle
Methodology Diagnostic-led, modular, tailored to your brand and budget  One-size-fits-all, quantity over quality
Flexibility Consultative — working collaboratively as strategy evolves Little adaptation to changing circumstances

Quote-Icon

The Brand Builder team has been my go-to for navigating rare disease markets, supporting me across two organizations and two novel molecules. Their advice is consistently insightful, clear, and actionable. I trust their expertise for any launch prep or pipeline commercialization effort.”

User Icon
Ernest Chow, Former Director
Global Brand Management, BioMarin

Brand Builder Within the ZoomRx Research Ecosystem

Combine brand launch research with ongoing tracking for complete market visibility.

Promotional Effectiveness
Tracking (PET)
Measure how promotional activity drives HCP behavior post-launch.
Learn more
Patient Chart
Audits (Patient Scribe)

Capture the clinical reasoning behind real-world treatment decisions.

Learn more
Brand Tracking
(ATU)
Monitor brand awareness, perception, and messaging uptake as your launch progresses.

 

Learn more
HCP-Patient
Conversations

Understand what happens inside the exam room — bridging physician intent and patient treatment decisions.

Learn more

Explore Insights

strategic-insights
Strategic Insights for Unbranded Disease Education Campaigns
read more
core-visual-AId
Core Visual Aid Research Drives Brand Optimization
read more
Target-Product-Profile
Target Product Profile (TPP) Optimization: Maximizing Launch Success Through Strategic Clinical Endpoints Evaluation
read more

CTA

Build Your Brand Launch Strategy with Confidence

Don’t let launch complexity dim the brilliance of your biopharma innovation. Partner with ZoomRx for a comprehensive pharma brand launch strategy that turns research investment into a confident, differentiated go-to-market plan.

Get in touch

Frequently Asked Questions

What is a pharma brand launch research program?

A pharma brand launch research program is a structured series of market research studies designed to help biopharma commercial teams answer the critical strategic questions needed to bring a new drug to market successfully. This includes understanding the competitive landscape, identifying target patient and physician profiles, mapping treatment decision journeys, and developing brand positioning and messaging. Brand Builder by ZoomRx organizes this work around the PHYCURE™ framework — ensuring every major launch decision is supported by dedicated research across all seven strategic dimensions.

What is the PHYCURE™ framework in pharma?

PHYCURE™ is a proprietary strategic framework developed by ZoomRx for biotech brand launches. Each letter stands for a foundational strategic dimension: Patient Target, HCP Target, Yes Journey, Competitive Landscape, Unmet Needs, Rational Benefits, and Emotional Benefits. Every dimension represents a question the commercial team must answer confidently before launch. Brand Builder provides comprehensive research insights to power each PHYCURE™ dimension from late Phase II through market entry.

When should a biopharma company begin brand launch research?

Brand Builder is designed to begin in late Phase II, supporting four sequential decisions: market assessment, strategic positioning, core messaging, and creative collateral development. Starting in late Phase II ensures each research phase informs the next — building a compounding strategic foundation well before launch day.

What are the key marketing decisions Brand Builder supports?

Brand Builder supports four key marketing decisions across the clinical development timeline: market assessment in late Phase II, establishing strategic positioning during Phase III, identifying core messaging from Phase III through launch, and developing creative collateral at launch. Each decision maps to dedicated research workstreams within the PHYCURE™ framework.

What does the Brand Builder diagnostic evaluation involve?

The Brand Builder diagnostic analyzes your brand across five key dimensions: competitive context (first in class, next generation, or new entry in an established class), audience type (specialist-, primary care-, patient-, or payer-centric), primary unmet needs (emotion-, function-, or outcomes-driven), messaging focus (efficacy, safety, convenience, or value), and revenue potential. This profile determines how the research program is structured and sequenced for your brand.